Myeloid Malignancies
Myeloid malignancies are cancers affecting blood stem cells and bone marrow, encompassing conditions such as myeloid leukemia, which specifically targets myeloid tissue. These malignancies disrupt normal blood cell production and can lead to serious health complications.
Health Outcomes
- Accelerated Recovery of Chemotherapy-Induced Myelosuppression
- Altered Hematology Profile
- Enhanced Hemocyte Count
- Improved Engraftment
- Improved Hematological Biomarker
- Improved Survival During Cryopreservation
- Increased G-CSF Production
- Increased Hemocyte Count
- Increased Vitamin B-12 Level
- Increased Vitamin B12 Concentration
- Increased Vitamin B12 Level
- Maintained Blood-Cell Counts
- Prevention of Haematological Parameter Decline
- Reduced Acute Graft-Versus-Host Disease
- Reduced Chronic Graft-Versus-Host Disease
- Reduced Complete Blood Count
- Reduced Cytotoxic Lymphocyte Count
- Reduced Granulocyte Levels
- Reduced Immunosuppression
- Reduced Interferon-gamma Level
- Reduced Neutrophil Count
- Reduced Thrombocytopenia
- Reduced Time to On Stage